Skip to content

Myocardial protection in cardiac surgery

Comparison the myocardial protection effect of modified Buck Berg Cardioplegia with modified Del Nido in adult patients under Mitral valve surgery

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20191024045227N1
Enrollment
74
Registered
2020-04-21
Start date
2018-04-21
Completion date
Unknown
Last updated
2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiopulmonary bypass. Nonrheumatic mitral valve disorder, unspecified

Interventions

Intervention 1: Intervention group: Intervention group: In the intervention group, the patient’s heart wa

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
22 Years to 72 Years

Inclusion criteria

Inclusion criteria: • Patients undergoing elective (first) mitral valve replacement or repair surgery for the first time • Patients with cardiopulmonary bypass who need cardiac arrest (cross-clamp and cardioplegia injection) • Age 22 - 72 years • EF equal or more than 40% preoperative • CPB time more than 60 min and less than 120 min • Having elective surgical consent • pulmonary artery pressure less than or equal to 50 mmHg preoperatively

Exclusion criteria

Exclusion criteria: • Previous Cardiac Surgery (Recurrent Patients) • EF less than 40% • pulmonary artery pressure more than 50 mmhg • Ventricular hypertrophy • Need for medication support (receiving inotropes before starting cardiac surgery) • Having a pacemaker or implantable cardioverter/defibrillator (ICD)

Design outcomes

Primary

MeasureTime frame
- Myocardial function. Timepoint: 1- pre operation 2 - post cardiopulmonary bypass 3 - post ICU 4 - post ICU. Method of measurement: 1- Echocardiography.;- ICU stay. Timepoint: Time to transfer the patient from the ICU to the post-ICU care unit. Method of measurement: Day of ICU stay.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAmene Ghanbari

Iran University of Medical Sciences

a.mghanbari@yahoo.com009823922424

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026